An Eli Lilly spokesperson said: "We expect Zepbound to be used as part of an ongoing disease management strategy for adults with obesity, in addition to a reduced-calorie diet and increased physical activity." The FDA told Fortune that it regulates the marketing and distribution of prescription drugs, and that companies are responsible for not misleading customers and being truthful in their product marketing, but the agency declined to comment on any specific companies and whether it had investigated or issued any warnings, noting that the FDA "generally does not comment on pending or potential compliance matters." 'We wanted to make sure that we stayed on message' Calibrate was one of the first weight-loss companies to enter what has become a saturated space
Seek new scientific information about the treatment of obesity, including the use of GLP-1 medications, and analyze how it impacts medical nutrition therapy
If youre concerned about safety, effectiveness, and cost, bariatric surgery may offer a more reliable path to lasting weight loss
It is important to note that since the drug is still being studied in clinical trials, researchers are still learning its full effects
Aegis Peptides does not provide advice on dosing, preparation, administration, injection, treatment, clinical use or personal use
Can it improve metabolic health